Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01879137

Enrollment

Registered

2013-06-17

Start date

2013-06-30

Completion date

2017-05-31

Last updated

2017-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Polyuria-polydipsia Syndrome

Keywords

Copeptin, Arginin stimulation test

Brief summary

the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Age over 18 years 2. No medication except hormonal contraception

Exclusion criteria

1. Evidence of any acute illness 2. Subjects refusing or unable to give written informed consent 3. Pregnancy 4. Any evidence of disordered drinking habits and diuresis

Design outcomes

Primary

Measure	Time frame
Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.	up to 120 minutes after the Arginine infusion.

Countries

Switzerland

Outcome results